Effect of Ring Fluorination on the Pharmacology of Hallucinogenic Tryptamines
The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
A series of fluorinated analogues of the hallucinogenic tryptamines N,N-diethyltryptamine (DET), 4-hydroxy-N,N-dimethyltryptamine (4-OH-DMT, psilocin), and 5-methoxy-DMT was synthesized to investigate possible explanations for the inactivity of 6-fluoro-DET as a hallucinogen and to determine the effects of fluorination on the molecular recognition and activation of these compounds at serotonin receptor subtypes. The target compounds were evaluated using in vivo behavioral assays for hallucinogen-like and 5-HT(1A) agonist activity and in vitro radioligand competition assays for their affinity at 5-HT(2A), 5-HT(2C), and 5-HT(1A) receptor sites. Functional activity at the 5-HT(2A) receptor was determined for all compounds. In addition, for some compounds functional activity was determined at the 5-HT(1A) receptor. Hallucinogen-like activity, evaluated in the two-lever drug discrimination paradigm using LSD-trained rats, was attenuated or abolished for all of the fluorinated analogues. One of the tryptamines, 4-fluoro-5-methoxy-DMT (6), displayed high 5-HT(1A) agonist activity, with potency greater than that of the 5-HT(1A) agonist 8-OH-DPAT. The ED(50) of 6 in the two-lever drug discrimination paradigm using rats trained to discriminate the 5-HT(1A) agonist LY293284 was 0.17 micromol/kg, and the K(i) at [(3)H]8-OH-DPAT-labeled 5-HT(1A) receptors was 0.23 nM. The results indicate that fluorination of hallucinogenic tryptamines generally has little effect on 5-HT(2A/2C) receptor affinity or intrinsic activity. Affinity at the 5-HT(1A) receptor was reduced, however, in all but one example, and all of the compounds tested were full agonists but with reduced functional potency at this serotonin receptor subtype. The one notable exception was 4-fluoro-5-methoxy-DMT (6), which had markedly enhanced 5-HT(1A) receptor affinity and functional potency. Although it is generally considered that hallucinogenic activity results from 5-HT(2A) receptor activation, the present results suggest a possible role for involvement of the 5-HT(1A) receptor with tryptamines.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“which may be a necessary property of effective hallucinogens.”
From Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans. (2021) · cites this paper as [14]
In the citing paper
“The corresponding Ki values against [123I]-DOI indicated ten-fold higher affinity at 5HT2A sites [10,14], which is presumably indicative of the greater competition between an agonist drug at agonist-labelled receptors, as has been established for the case of dopamine D2/3 receptors [46].”
From Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans. (2021) · cites this paper as [14]
Citations
Cites
A SIMPLIFIED METHOD OF EVALUATING DOSE-EFFECT EXPERIMENTS
LITCHFIELD, J. T., & WILCOXON, F. (1949) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)03549-9 · Cited by 7,812
How good is fluorine as a hydrogen bond acceptor?
Howard, J. A. K., Hoy, V. J., O'Hagan, D., & Smith, G. T. (1996) · Tetrahedron · doi:10.1016/0040-4020(96)00749-1 · Cited by 737
Titeler, M., Lyon, R. A., & Glennon, R. A. (1988) · Psychopharmacology · doi:10.1007/bf00176847 · Cited by 343
Schreiber, R., Brocco, M., Audinot, V, Gobert, A., Veiga, S., & Millan, M. J. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09485-6 · Cited by 300
CYCLOPENTADIENYL COMPOUNDS OF Sc, Y, La, Ce AND SOME LANTHANIDE ELEMENTS
Wilkinson, G., & Birmingham, J. M. (1954) · Journal of the American Chemical Society · doi:10.1021/ja01652a114 · Cited by 272
Human psychopharmacology of N,N-dimethyltryptamine
Strassman, R. J. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00081-2 · Cited by 261
Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes
Mckenna, D. J., Repke, D. B., Lo, L., & Peroutka, S. J. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90001-8 · Cited by 192
Characteristics of C-F Systems
Smart, B. E. (1994) · Organofluorine Chemistry · doi:10.1007/978-1-4899-1202-2_3 · Cited by 187
Inter-animal olfactory cues in operant drug discrimination procedures in rats
Extance, K., & Goudie, A. J. (1981) · Psychopharmacology · doi:10.1007/bf00426467 · Cited by 170
Drug discrimination studies with MDMA and amphetamine
Oberlender, R. A., & Nichols, D. (1988) · Psychopharmacology · doi:10.1007/bf00212770 · Cited by 152
Self-citation
Research works printed but not linked: 32
- LeBars D., 1987, Appl. Radiat. Isot., 38, 1077
- Kirk K. L, 1975, J. Org. Chem., 41, 2376
- Kirk K. L, 1976, J. Heterocycl. Chem., 13, 1256
- Janssen P. A, 1965, Int. Rev. Neurobiol., 8, 263
- Smart B. E., 1994, Organofluorine Chemistry: Principles and Commercial Applications (Topics in Applied Chemistry), 88
- Park B. K., 1994, Drug Metab. Rev., 26, 643
- Howard J. A. K., 1996, Tetrahedron, 52, 12622
- Bentov M., 1962, J. Chem. Soc., 2825, 2827
- Aldred R., 1994, J. Chem. Soc., Perkin Trans. 1, 1823, 1831
- Adams R. E., 1991, Synth. Commun., 12, 681
- Speeter M. E., 1954, J. Am. Chem. Soc., 76, 6210
- Chen C., 1994, J. Org. Chem., 59, 3741
- Hoggett J. G., 1969, Chem. Commun., 605, 606
- Desaty D., 1964, Croat. Chem. Acta, 36, 109
- Arnt J, 1989, Pharmacol. Toxicol., 64, 172
- Nichols D. E., 1997, Handbook of Experimental Pharmacology. Serotoninergic neurons and 5-HT Receptors in the CNS, 585
- Marona-Lewicka D., 1997, Soc. Neurosci. Abstr., 23
- Kleven M. S., 1997, J. Pharmacol. Exp. Ther., 282, 759
- Darmani N. A., 1996, Pharmacol. Biochem. Behav., 55, 10
- Darmani N. A, 1998, J. Neural Transm., 105, 643
- Strassman R. J, 1996, Behav. Brain Res., 73, 124
- Schreiber R., 1995, J. Pharmacol. Exp. Ther., 273, 112
- Glennon R. A., 1991, Drug Discrimination: Applications to Drug Abuse Research, 44
- Kuipers W., 1994, Drug Des. Discov., 11, 249
- Gallaher T. K., 1993, Med. Chem. Res., 3, 66
- Johnson M. P., 1994, Mol. Pharmacol., 45, 286
- Bergmann E. D., 1959, J. Chem. Soc., 1913, 1914
- Niemann C., 1941, J. Am. Chem. Soc., 63, 611
- Foreman M. M., 1994, J. Pharmacol. Exp. Ther., 270, 1281
- Litchfield J. T., 1949, J. Pharmacol. Exp. Ther., 96, 113
- Berg K. A., 1994, Mol. Pharmacol., 46, 484
- Watts V. J., 1996, Mol. Pharmacol., 50, 976
Cited by
Items 101–136 of 136
Complete biosynthesis of psychedelic tryptamines from three kingdoms in plants
Berman, P., Hófer, J. H., Mehlman, H., Almekias‐Siegl, E., Khersonsky, O., Dong, Y., Heinig, U., Sulimani, L., Hao, L. K., Cohen, S., et al. (2026) · Science Advances · doi:10.1126/sciadv.aeb3034 · Cited by 5
“Fluorination at the 6 or 7 position of psilocin 16 has also been linked to increased 5-HT 2A receptor affinity ( 31 ).”
Synthesis of Fluorinated Indoles as RNA Analogues
Božilović, J., & Engels, J. W. (2007) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770701505220 · Cited by 4
“SYNTHESIS The synthesis of fluoroindoles (which are not commercial available) was achieved very efficiently in a four step procedure as shown in Figure 1.[3,4] Methyl azidoacetate, an intermediate in indole synthesis was synthesized by literature procedure.”
MethodSerotonin and serotonin receptors in hallucinogen action
Halberstadt, A. L., & Nichols, D. E. (2020) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-444-64125-0.00043-8 · Cited by 7
Self-citationNoback, M. N., Kenton, J. A., Klein, A. K., Hughes, Z. A., Kruegel, A. C., Schmid, Y., Halberstadt, A. L., & Young, J. W. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110334 · Cited by 3
5-Hydroxytryptamine receptors in GtoPdb v.2023.1
Andrade, R., Barnes, N. M., Baxter, G., Bockaert, J., Branchek, T. A., Butler, A. S., Cohen, M. L., Dumuis, A., Eglen, R. M., Göthert, M., et al. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f1/2023.1 · Cited by 3
Cyclization of Vinyl and Aryl Azides into Pyrroles, Indoles, Carbazoles, and Related Fused Pyrroles
Berkowitz, W. F., & McCombie, S. W. (2017) · Organic reactions · doi:10.1002/0471264180.or092.02 · Cited by 3
Effects of Psilocybin on Mouse Brain Microstructure
Frautschi, P. C., Singh, A. P., Stowe, N. A., Grady, S. M., Zahid, Z., Banks, M. I., & Yu, J. J. (2025) · American Journal of Neuroradiology · doi:10.3174/ajnr.a8634 · Cited by 2
de Sousa-Silva, A. N., Moura, C. D. A., Torres, C. I. D. O., Marques, V. B., Silva, J. M. D. N., Soares, B. L., Silva, S. R. B., Coelho, N. L. G., Palhano-Fontes, F., de Araújo, D. B., et al. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.110947 · Cited by 2
Rhyman, L., Alswaidan, I. A., Fun, H., JOULE, J. A., & Ramasami, P. (2015) · Tetrahedron · doi:10.1016/j.tet.2015.02.012 · Cited by 2
Jerome, L. (2007) · Cited by 2
Psilocybin inhibits formalin-induced nociception through 5-hydroxytryptamine 2A receptor in rats
Inan, S., Morris, P., Rawls, S. M., & Daws, S. E. (2025) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000856 · Cited by 1
Bhat, A., Zolali, E., Sakib, M. A., Rahimian, M., McMahon, L. R., German, N., & Obeng, S. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00202 · Cited by 2
1-{(E)-[(2-Fluoro-5-nitrophenyl)imino]methyl}naphthalen-2-ol
Kennedy, A. R., Akkurt, M., Abdelhamid, A. A., Mohamed, S. K., & Miller, G. J. (2013) · Acta Crystallographica Section E Structure Reports Online · doi:10.1107/s1600536813012099 · Cited by 1
“For the significance of fluorine atoms in drug structures, see: Blair et al. (2000); Kirk et al. (1979); LeBars et al. (1987).”
Background4-Bromo-2-[(E)-{[4-nitro-2-(trifluoromethyl)phenyl]imino}methyl]phenol
Akkurt, M., Kennedy, A. R., Mohamed, S. K., Abdelhamid, A. A., & Miller, G. J. (2012) · Acta Crystallographica Section E Structure Reports Online · doi:10.1107/s1600536812042262 · Cited by 1
“Fluorine can dramatically change the properties of biologically active compounds and can influence the metabolism and distribution of drug molecules in the body (Blair et al., 2000).”
BackgroundGribble, G. W. (2016) · doi:10.1002/9781118695692.ch28 · Cited by 1
(2010) · Comprehensive Organic Name Reactions and Reagents · doi:10.1002/9780470638859.conrr306 · Cited by 1
Gudmundsen, F., Czurylo, J., Vo, C. T., Ruuska, J., Jessen, N. S., Baun, C., Herth, M. M., Shalgunov, V., Fisher, P. M., & Palner, M. (2024) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/mq4v2 · Cited by 2
4-Bromo-2-[(E)-(2-fluoro-5-nitrophenyl)iminomethyl]phenol
Mohamed, S. K., Akkurt, M., Horton, P. N., Abdelhamid, A. A., & Marzouk, A. A. E. (2012) · Acta Crystallographica Section E Structure Reports Online · doi:10.1107/s1600536812050696
“Among such compounds, the fluorinated Schiff's bases were considered to possess a distingushed biological activity due to the dramatic affect of fluorine atom on the metabolism and distribution of drug molecules in the body (Blair et al., 2000).”
BackgroundMattsson, C. M. (2013) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
Signal transduction and G-protein incorporation properties of human serotonin 1A receptors
Thiagaraj, H. V. (2002) · The Mathematics Enthusiast
ChemInform Abstract: Effect of Ring Fluorination on the Pharmacology of Hallucinogenic Tryptamines.
Blair, J. B., Kurrasch‐Orbaugh, D. M., Marona‐Lewicka, D., Cumbay, M. G., Watts, V. J., Barker, E. L., & Nichols, D. E. (2001) · ChemInform · doi:10.1002/chin.200111113
Self-citationBockaert, J. (2010) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.5666958.5641056
Mason, N. L. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210608nm · Cited by 1
Dwulet, G. E. (2024) · RSC Medicinal Chemistry · doi:10.1039/d4md00262h
Behavioral effects of three synthetic tryptamine derivatives in rodents
Hill, R. D., Shetty, R. A., Sumien, N., Priddy, J., Forster, M. J., & Gatch, M. B. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251330737
“Only one study examined a 5Cl substituted tryptamine, but one study reported that fluorina tion at the 5position “attenuated or abolished” substitution for LSD (Blair et al., 2000).”
Wood, B. J., Vest, M. F., Carfagno, C., Bartley, K. R., Sharma, P., Halberstadt, A. L., Blough, B. E., & Murnane, K. S. (2026) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00484
Trip killers: Addressing a critical knowledge gap in psychedelic research
O’Mahony, B. W., Harrington, C., Harkin, A., & Lally, N. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261431056
“In addition to the 5-HT 2A receptor, classic psychedelics also act on other serotonergic receptor sites (Blair et al., 2000; McKenna et al., 1990).”
Kaadt, E., Søkilde, R., Hansen, H. D., Raval, N. R., Donovan, L. L., Just, J., Knudsen, G. M., & Elfving, B. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179222
The Emergence of Isotryptamine Analogs as Novel Serotonergic Agents with Psychotherapeutic Potential
Glennon, R. A., & Dukat, M. (2026) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.6c00288
Orallo, D. E., Parise, A. R., Echarte, S. M., Iurlina, M. O., & Ramírez, C. L. (2026) · Studies in natural products chemistry · doi:10.1016/b978-0-443-51072-4.00016-8
Klein, L. M., Kopelman, J., Sharp, R. F., Powell, S., Geyer, M. A., Young, J. W., & Halberstadt, A. (2026) · Psychopharmacology · doi:10.1007/s00213-026-07181-x
BindingDB (2009) · UC San Diego · doi:10.7270/q2ww7h66
Metadata
- Authors
- Blair, J. B., Kurrasch-Orbaugh, D., Marona-Lewicka, D., Cumbay, M. G., Watts, V. J., Barker, E. L., & Nichols, D. E.
- Affiliations
- Purdue University West Lafayette (US)
- Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, Indiana 47907
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2000-10-19
- Volume
- 43
- Issue
- 24
- Pages
- 4701-4710
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W1972426098
- Cited by
- 131
- References
- 56
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 7 · 2023: 7 · 2022: 7 · 2021: 5 · 2020: 11 · 2019: 4 · 2018: 5 · 2017: 4 · 2016: 7 · 2015: 6 · 2014: 2 · 2013: 5 · 2012: 5
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA 02189)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- fluorination, 5-HT2A receptor, 5-HT2C receptor, 5-HT1A receptor, drug discrimination, 8-OH-DPAT
- MeSH terms
- Cyclic AMP, Animals, Binding, Competitive, Discrimination Learning, Drug Evaluation, Preclinical, Fluorine, Colforsin, Hallucinogens, Cricetinae, Humans, Hydrolysis, Phosphatidylinositols, Radioligand Assay, Receptors, Serotonin, Structure-Activity Relationship, Tryptamines, CHO Cells, 3T3 Cells, Serotonin Receptor Agonists, Receptors, Serotonin, 5-HT1, Receptor, Serotonin, 5-HT2A, Receptor, Serotonin, 5-HT2C, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.